JPMorgan Chase & Co’s DMK Pharmaceuticals Corporation Common Stock DMK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-106,209
| Closed | -$74.4K | – | 6823 |
|
|
2023
Q4 | $74.4K | Buy |
106,209
+71,503
| +206% | +$50.1K | ﹤0.01% | 4882 |
|
|
2023
Q3 | $23.9K | Buy |
34,706
+33,022
| +1,961% | +$22.8K | ﹤0.01% | 5108 |
|
|
2023
Q2 | $4.03K | Buy |
1,684
+1,678
| +27,967% | +$4.01K | ﹤0.01% | 5313 |
|
|
2023
Q1 | $0 | Hold |
6
| – | – | ﹤0.01% | 6227 |
|
|
2022
Q4 | $0 | Sell |
6
-2
| -25% | – | ﹤0.01% | 6068 |
|
|
2022
Q3 | $0 | Sell |
8
-403
| -98% | – | ﹤0.01% | 5936 |
|
|
2022
Q2 | $14K | Sell |
411
-800
| -66% | -$27.3K | ﹤0.01% | 5129 |
|
|
2022
Q1 | $48K | Sell |
1,211
-1,911
| -61% | -$75.7K | ﹤0.01% | 5030 |
|
|
2021
Q4 | $132K | Buy |
3,122
+2,748
| +735% | +$116K | ﹤0.01% | 4720 |
|
|
2021
Q3 | $25K | Sell |
374
-239
| -39% | -$16K | ﹤0.01% | 5099 |
|
|
2021
Q2 | $47K | Buy |
613
+444
| +263% | +$34K | ﹤0.01% | 4961 |
|
|
2021
Q1 | $11K | Buy |
+169
| New | +$11K | ﹤0.01% | 5022 |
|
|
2020
Q4 | – | Sell |
-239
| Closed | -$13K | – | 5165 |
|
|
2020
Q3 | $13K | Buy |
+239
| New | +$13K | ﹤0.01% | 4566 |
|